Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT05335356 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

384

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Chronic Plaque Psoriasis

Interventions

BIOLOGICAL: Stelara
BIOLOGICAL: Bmab1200

Sponsor

Biocon Biologics UK Ltd